Supriya Lifescience IPO Date, Review, Price, Form & Market Lot Details

Supriya Lifescience is established in 1987 by Satish Waman Wagh are the promoters of the company.

Supriya Lifescience IPO: Supriya Lifescience is a company that produces active medicinal components (APIs). As of March 31, 2021, the firm produces 38 APIs in the antihistamine, analgesic, anaesthetic, vitamin, anti-asthmatic, and anti-allergic therapeutic segments. Between Fiscal 2017 and Fiscal 2021, the company was the largest exporter of Chlorpheniramine Maleate and Ketamine Hydrochloride from India. In terms of volume, the company is also one of India's major exporters of Salbutamol Sulphate in FY 2021.

In Fiscal 2021, the company's products were shipped to 1,296 clients, including 346 distributors, in 86 countries. API business is done by the corporation across Europe, Latin America, Asia, and North America.

Financial Record of the last year (In Millions)

Financial Period : 30-Sep-2021 (Restated Consolidated)
Total Assets : 5,041.02
Total Revenue : 2,300.61
Profit After Tax : 659.59
Basic Earnings Per Share (EPS) FY2021 : 16.92 INR

Supriya Lifescience IPO GMP & Grey Market Premium

Check Supriya Lifescience IPO Grey Market Activities Day By Day

Supriya Lifescience IPO Subscription Status

Check Supriya Lifescience IPO Subscription Status Day By Day

Supriya Lifescience IPO DRHP

Click Here

Supriya Lifescience IPO Allotment Date & Details

Registrar of Supriya Lifescience IPO

Link Intime India Private Ltd
C 101, 247 Park, L.B.S.Marg,
Vikhroli (West), Mumbai - 400083
Website: https://linkintime.co.in/
Email: [email protected]
Phone: +91-22-4918 6270
Fax: +91-22-4918 6060

Supriya Lifescience Contact Details

Supriya Lifescience Limited
207/208, Udyog Bhavan,
Sonawala Road, Goregaon,
East, Mumbai – 400063, Maharashtra, India
Phone: +91-22-40332727
Email: [email protected]
Website: https://supriyalifescience.com/